Senior Leadership

Barry Fishman (Chief Executive Officer)

20 years as a business leader, most recently as CEO
of European-focused speciality pharmaceutical
company Merus Labs. Previously served as CEO of
both Teva Canada and Taro Canada.

Dr. Michael Bumby (Chief Financial Officer)

20 years of experience in pharmaceuticals, previously CFO of three publicly held Canadian companies -
most recently as CFO of Merus Labs

Ray Laflamme (SVP, Facilities and Engineering)

45 years of engineering, design, construction, project
management experience. Commissioned several industrial food grade facilities in North America including the Canna Farms’ facility.

Daniel Laflamme (President, Canna Farms)

Over 15 years of financial, operational and regulatory
business experience. Prior to founding CF, was Managing Director for Amberwood Homes.

Andrew LaCroix (VP, International and General Counsel)

Over 20 years of legal experience starting at Stikeman
and then his own legal practice.

Joel Mallard (Chief C Officer)

20 years of sales and marketing experience at Diageo
and Cowbell Brewing Co.

Shekhar Parmar (CEO, Harvest Medicine and Chief Strategy Officer)

Over 10 years of experience as an entrepreneur,
lawyer, and design thinker.

Board of Directors

Paul Lucas

(Chairman)
Former CEO of Glaxo
Canada with significant board experience in for-profit & non-profit sectors.

Barry Fishman

Chief Executive Officer
20 years as a business leader, most recently as CEO
of European-focused speciality pharmaceutical
company Merus Labs. Previously served as CEO of
both Teva Canada and Taro Canada.

Daryl Kramp

Member of Parliament,
Municipal Counsellor,
and successful
entrepreneur.

Richard Fitzgerald

Former CEO & Chairman
of Diageo Canada – broad
leadership experience in
alcohol and tobacco.

Aaron Keay

Creative capital markets expert with deep
experience M&A and
take-public transactions

Daniel Laflamme

Co-founder of CannaFarms.
Seasoned entrepreneur with
broad cultivation and
operational experience.

John Easson

Corporate finance and M&A Advisor
Experiences ranging from start-ups
to Canada’s largest
public companies.

Scientific Advisory

VIVO Cannabis’ ambition to provide its customers and patients with best-in-class offerings begins with the support of leading scientific advisors. VIVO Cannabis’ products and practices are informed by a distinguished group of scientific advisors, made up of the foremost experts in cannabis research and plant science.

Raphael Mechoulam, PhD

The world-renowned cannabis scientist that
discovered tetrahydrocannabinol (THC) and
cannabidiol (CBD).

Mike Dixon, PhD

Leading globally recognized plant scientist –
specializing in controlled environmental systems.

Donald I. Abrams, MD

Cancer and integrative medicine specialist.
Co-Author of The Chapter Cannabinoids
and Cancer in the Oxford University Press.

Corporate Governance

Our board is committed to good corporate governance. We invite you to learn more about our policies and practices: